Cargando…
RIG-I-induced innate antiviral immunity protects mice from lethal SARS-CoV-2 infection
The SARS-CoV-2 pandemic has underscored the need for rapidly usable prophylactic and antiviral treatments against emerging viruses. The targeted stimulation of antiviral innate immune receptors can trigger a broad antiviral response that also acts against new, unknown viruses. Here, we used the K18-...
Autores principales: | Marx, Samira, Kümmerer, Beate M., Grützner, Christian, Kato, Hiroki, Schlee, Martin, Renn, Marcel, Bartok, Eva, Hartmann, Gunther |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Society of Gene & Cell Therapy
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8841011/ https://www.ncbi.nlm.nih.gov/pubmed/35186439 http://dx.doi.org/10.1016/j.omtn.2022.02.008 |
Ejemplares similares
-
RIG-I immunotherapy overcomes radioresistance in p53-positive malignant melanoma
por: Lambing, Silke, et al.
Publicado: (2023) -
Structural and functional insights into pattern recognition by the innate immune receptor RIG-I
por: Wang, Yanli, et al.
Publicado: (2010) -
A Conserved Histidine in the RNA Sensor RIG-I Controls Immune Tolerance to N(1)-2′O-Methylated Self RNA
por: Schuberth-Wagner, Christine, et al.
Publicado: (2015) -
Antiviral immunity via RIG-I-mediated recognition of RNA bearing 5′-diphosphates
por: Goubau, Delphine, et al.
Publicado: (2014) -
Emerging complexity and new roles for the RIG-I-like receptors in innate antiviral immunity
por: Errett, John S., et al.
Publicado: (2015)